Murray A. Raskind | Psychiatrist.com

Original Research

The ɑ1-Adrenergic Antagonist Prazosin Ameliorates Combat Trauma Nightmares in Veterans With Posttraumatic Stress Disorder: A Report of 4 Cases

Letter to the Editor

Beneficial Effects of Prazosin for Visual Hallucinations Associated With Chronic Cocaine Abuse

Article

The Clinical Interface of Depression and Dementia

Letter to the Editor

Dosing by Side Effect Threshold: Two Cases of Panic Disorder Responsive to Low-Dose Venlafaxine

Article

Doxazosin XL for PTSD

One alpha-1 noradrenergic antagonist drug has shown promise in treating PTSD-related sleep disturbances and nightmares, but it has a short half-life. Could the long half-life version of this type...

Original Research

The Effects of Metrifonate on the Cognitive, Behavioral, and Functional Performance of Alzheimer's Disease Patients

Article

Evaluation and Management of Aggressive Behavior in the Elderly Demented Patient

Original Research

Prazosin Reduces Nightmares in Combat Veterans With Posttraumatic Stress Disorder

Article

Psychopharmacology of Noncognitive Abnormal Behaviors in Alzheimer's Disease

Letter to the Editor

Reply to Letter to the Editor "Metrifonate for Alzheimer's Disease Patients"